SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020

SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020

Bibliographic Details
Main Authors:	Shichun Wang, Min Song, Qi Liu, Chunyan Yao
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664622000043

Similar Items

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
by: Jonathan Mandolo, et al.
Published: (2021-11-01)

Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats
by: Daniel J. Nesbitt, et al.
Published: (2021-08-01)

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
by: Sheila F. O’Brien, et al.
Published: (2022-10-01)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
by: Dianna L. Ng, et al.
Published: (2020-09-01)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
by: Martina Ferrari, et al.
Published: (2023-07-01)

SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021
by: Pierre Gallian, et al.
Published: (2023-04-01)

SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
by: Luca Cegolon, et al.
Published: (2023-07-01)

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
by: Manoj V. Murhekar, et al.
Published: (2021-07-01)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
by: Uyoga, S, et al.
Published: (2021)

Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
by: Ryo Kinoshita, et al.
Published: (2023-09-01)

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
by: Sheila F. O’Brien, et al.
Published: (2023-02-01)

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era
by: Cassandra N. Reedman, et al.
Published: (2022-04-01)

Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
by: Ravit Bassal, et al.
Published: (2022-10-01)

Seroprevalence of anti-SARS-CoV-2 antibodies among blood donors from December 2020 to June 2021 in Koutiala district, Mali.
by: Fara Wagbo Temessadouno, et al.
Published: (2023-01-01)

Seroprevalence of anti-SARS-CoV-2 antibodies among blood donors from December 2020 to June 2021 in Koutiala district, Mali
by: Fara Wagbo Temessadouno, et al.
Published: (2023-01-01)

Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
by: Luiz Amorim Filho, et al.
Published: (2020-07-01)

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
by: Ed Slot, et al.
Published: (2020-11-01)

SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020
by: Huan Han, et al.
Published: (2021-04-01)

Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01)

Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
by: Ayman Banjar, et al.
Published: (2021-03-01)

Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
by: Brittany K. Smith, et al.
Published: (2021-08-01)

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
by: Thompson, CP, et al.
Published: (2020)

SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy
by: Serena Marchi, et al.
Published: (2022-06-01)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
by: Etyang, AO, et al.
Published: (2022)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
by: Anthony O Etyang, et al.
Published: (2022-01-01)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
by: Anthony O. Etyang, et al.
Published: (2022-01-01)

Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
by: Anna-Lisa Sorg, et al.
Published: (2022-06-01)

Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
by: Amy K. Feehan, et al.
Published: (2020-11-01)

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis
by: Joyeuse Ukwishaka, et al.
Published: (2024-10-01)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Fayoum, Egypt
by: Abeer Abdelrazik, et al.
Published: (2023-01-01)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
by: Cruz S. Sebastião, et al.
Published: (2021-11-01)

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
by: Natalia Martinez-Acuña, et al.
Published: (2021-06-01)

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
by: Anthony Nardone, et al.
Published: (2022-08-01)

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
by: Lewis, HC, et al.
Published: (2022)

U.S. CDC support to international <i>SARS-CoV-2</i> seroprevalence surveys, May 2020-February 2022.
by: Amen Ben Hamida, et al.
Published: (2022-08-01)

Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy.
by: Valeria Cento, et al.
Published: (2020-01-01)

SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020–January 2022
by: Aubrey D. Kehoe, et al.
Published: (2024-05-01)

Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
by: May Raouf, et al.
Published: (2021-07-01)

Seroprevalence of SARS-CoV-2 IgG Antibodies in Blood Donors during the Third Wave of Pandemic in Northern Pakistan
by: Muhammad Ali Rathore, et al.
Published: (2024-08-01)

Seroprevalence of SARS-CoV-2 IgG in blood donors in a teaching institute from Western part of Maharashtra
by: Rajashri A. Patil, et al.
Published: (2024-05-01)